Form 4: Cartesian Therapeutics Chief Medical Officer Milos Miljkovic Executes Stock Option and Sells Shares

Cartesian Therapeutics' Chief Medical Officer, Milos Miljkovic, exercised stock options and sold shares on November 14th and 15th, 2024.

Summary

• Milos Miljkovic, Chief Medical Officer of Cartesian Therapeutics, exercised stock options to acquire 55,000 shares of common stock at a price of $3.23 per share.
• He then sold 55,000 shares of common stock in multiple transactions at weighted average prices of $16.1327 and $17.1444 per share on November 14th and 15th, 2024 respectively.
• Following these transactions, Miljkovic directly owns 18,273 shares of common stock and 30,528 stock options.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing detailing stock transactions by an executive. It doesn't indicate any positive or negative sentiment about the company's performance.

Industry Context

This is a standard SEC Form 4 filing, which is common for company insiders who trade their company's stock. It provides transparency into the transactions of key personnel.

Comparison to Industry Standards

• SEC Form 4 filings are a standard practice for publicly traded companies in the United States.
• The transactions are typical for executives who receive stock options as part of their compensation.
• The weighted average sale prices are within the range of the reported transaction prices, which is consistent with market practices.

Stakeholder Impact

• The transactions may have a minor impact on the stock price due to the increased supply of shares in the market.

Key Dates

Keywords

stock options, insider trading, common stock, SEC Form 4, Cartesian Therapeutics, Milos Miljkovic, share sales